These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25953731)

  • 21. Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine.
    Akazawa T; Yoshida S; Ohnishi S; Kanazu T; Kawai M; Takahashi K
    Drug Metab Dispos; 2018 Nov; 46(11):1497-1506. PubMed ID: 30135242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation Capacity of Carboxylesterase in Skin and Keratinocytes for the Penta-Ethyl Ester Prodrug of DTPA.
    Fu J; Sadgrove M; Marson L; Jay M
    Drug Metab Dispos; 2016 Aug; 44(8):1313-8. PubMed ID: 27130352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal permeability of lamivudine (3TC) and two novel 3TC prodrugs. Experimental and theoretical analyses.
    Gualdesi MS; Briñón MC; Quevedo MA
    Eur J Pharm Sci; 2012 Dec; 47(5):965-78. PubMed ID: 23072916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outward transfer of dopamine precursor L-3,4-dihydroxyphenylalanine (L-dopa) by native and human P-glycoprotein in LLC-PK(1) and LLC-GA5 col300 renal cells.
    Soares-Da-Silva P; Serrão MP
    J Pharmacol Exp Ther; 2000 May; 293(2):697-704. PubMed ID: 10773046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine.
    Okudaira N; Komiya I; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Nov; 295(2):717-23. PubMed ID: 11046110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate-Competitive Activity-Based Profiling of Ester Prodrug Activating Enzymes.
    Xu H; Majmudar JD; Davda D; Ghanakota P; Kim KH; Carlson HA; Showalter HD; Martin BR; Amidon GL
    Mol Pharm; 2015 Sep; 12(9):3399-407. PubMed ID: 26262434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of transport mechanism of prodrugs and parent drugs formed by intracellular metabolism in Caco-2 cells with modified carboxylesterase activity: temocapril as a model case.
    Ohura K; Nozawa T; Murakami K; Imai T
    J Pharm Sci; 2011 Sep; 100(9):3985-94. PubMed ID: 21618543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino acid prodrug of quinidine: an approach to circumvent P-glycoprotein mediated cellular efflux.
    Patel M; Mandava NK; Pal D; Mitra AK
    Int J Pharm; 2014 Apr; 464(1-2):196-204. PubMed ID: 24440401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distribution of esterases in the skin of the minipig.
    Jewell C; Prusakiewicz JJ; Ackermann C; Payne NA; Fate G; Williams FM
    Toxicol Lett; 2007 Sep; 173(2):118-23. PubMed ID: 17719730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea.
    Katragadda S; Talluri RS; Mitra AK
    J Ocul Pharmacol Ther; 2006 Apr; 22(2):110-20. PubMed ID: 16722797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol.
    Tang M; Mukundan M; Yang J; Charpentier N; LeCluyse EL; Black C; Yang D; Shi D; Yan B
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1467-76. PubMed ID: 16943252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo evaluations of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318. Roles of efflux and metabolism.
    Prueksaritanont T; DeLuna P; Gorham LM; Ma B; Cohn D; Pang J; Xu X; Leung K; Lin JH
    Drug Metab Dispos; 1998 Jun; 26(6):520-7. PubMed ID: 9616186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fexofenadine transport in Caco-2 cells: inhibition with verapamil and ritonavir.
    Perloff MD; von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 2002 Nov; 42(11):1269-74. PubMed ID: 12412827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective evasion of P-glycoprotein, cytochrome P450 3A, and hydrolases by peptide prodrug modification of saquinavir.
    Wang Z; Pal D; Mitra AK
    J Pharm Sci; 2012 Sep; 101(9):3199-213. PubMed ID: 22611042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug.
    Mandal A; Pal D; Mitra AK
    Int J Pharm; 2016 Oct; 512(1):49-60. PubMed ID: 27543355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique.
    Fortuna A; Alves G; Falcão A; Soares-da-Silva P
    Epilepsia; 2012 Mar; 53(3):529-38. PubMed ID: 22372629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Segmental differences in drug permeability, esterase activity and ketone reductase activity in the albino rabbit intestine.
    Narawane M; Podder SK; Bundgaard H; Lee VH
    J Drug Target; 1993; 1(1):29-39. PubMed ID: 7915178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.